Market Cap | 87.86M | P/E | - | EPS this Y | 128.30% | Ern Qtrly Grth | - |
Income | -3.4M | Forward P/E | 64.80 | EPS next Y | 46.20% | 50D Avg Chg | 7.00% |
Sales | 51.66M | PEG | 2.47 | EPS past 5Y | - | 200D Avg Chg | 21.00% |
Dividend | N/A | Price/Book | 18.95 | EPS next 5Y | 15.00% | 52W High Chg | -34.00% |
Recommedations | 2.00 | Quick Ratio | 0.62 | Shares Outstanding | 13.59M | 52W Low Chg | 73.00% |
Insider Own | 25.56% | ROA | -6.93% | Shares Float | 4.89M | Beta | 0.46 |
Inst Own | 50.57% | ROE | -432.46% | Shares Shorted/Prior | 327.73K/48.43K | Price | 6.48 |
Gross Margin | 44.27% | Profit Margin | -6.58% | Avg. Volume | 9,067 | Target Price | - |
Oper. Margin | 9.45% | Earnings Date | Dec 10 | Volume | 7,138 | Change | 0.00% |
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Craig-Hallum | Buy | Sep 12, 24 |
Craig-Hallum | Hold | Mar 13, 24 |
Roth MKM | Buy | Sep 22, 23 |
Roth Capital | Buy | Mar 15, 21 |
Benchmark | Speculative Buy | Nov 18, 19 |
Roth Capital | Buy | Sep 20, 19 |
Janney Montgomery Scott | Neutral | Jul 24, 19 |
Craig-Hallum | Buy | Jul 17, 18 |
Dawson James | Buy | May 15, 18 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Mendelson Daniel Newman | Director Director | Jan 12 | Buy | 6.50 | 1,000 | 6,500 | 198,625 | 01/16/24 |
Mendelson Daniel Newman | Director Director | Jan 11 | Buy | 6.27 | 2,000 | 12,540 | 197,625 | 01/12/24 |
Mendelson Daniel Newman | Director Director | Jan 10 | Buy | 6.31 | 2,944 | 18,577 | 195,625 | 01/11/24 |
Mendelson Daniel Newman | Director Director | Jan 09 | Buy | 6.25 | 3,000 | 18,750 | 192,681 | 01/10/24 |
Mendelson Daniel Newman | Director Director | Jan 08 | Buy | 6.15 | 1,000 | 6,150 | 189,681 | 01/09/24 |
Mendelson Daniel Newman | Director Director | Dec 21 | Buy | 4.92 | 2,500 | 12,300 | 183,181 | 12/26/23 |
Mendelson Daniel Newman | Director Director | Dec 20 | Buy | 4.82 | 2,100 | 10,122 | 180,681 | 12/21/23 |
Mendelson Daniel Newman | Director Director | Dec 19 | Buy | 4.75 | 5,000 | 23,750 | 178,581 | 12/20/23 |
Mendelson Daniel Newman | Director Director | Sep 29 | Buy | 6.16 | 4,000 | 24,640 | 173,581 | 10/16/23 |
Mendelson Daniel Newman | Director Director | Sep 28 | Buy | 6.22 | 5,000 | 31,100 | 169,581 | 10/16/23 |
Mendelson Daniel Newman | Director Director | Sep 27 | Buy | 5.95 | 1,500 | 8,925 | 164,581 | 10/16/23 |
Mendelson Daniel Newman | Director Director | Oct 11 | Buy | 6.40 | 5,000 | 32,000 | 163,081 | 10/13/23 |
Mendelson Daniel Newman | Director Director | Oct 06 | Buy | 6.48 | 1,530 | 9,914 | 156,981 | 10/10/23 |
Mendelson Daniel Newman | Director Director | Oct 05 | Buy | 6.47 | 2,000 | 12,940 | 155,451 | 10/06/23 |
Mendelson Daniel Newman | Director Director | Oct 03 | Buy | 6.30 | 2,500 | 15,750 | 148,451 | 10/04/23 |
Mendelson Daniel Newman | Director Director | Oct 04 | Buy | 6.40 | 5,000 | 32,000 | 153,451 | 10/04/23 |
Mendelson Daniel Newman | Director Director | Sep 26 | Buy | 5.65 | 5,000 | 28,250 | 145,951 | 09/27/23 |
Mendelson Daniel Newman | Director Director | Sep 19 | Buy | 5.28 | 5,000 | 26,400 | 128,121 | 09/25/23 |
Mendelson Daniel Newman | Director Director | Sep 20 | Buy | 5.51 | 4,018 | 22,139 | 132,139 | 09/25/23 |
Mendelson Daniel Newman | Director Director | Sep 21 | Buy | 5.51 | 5,000 | 27,550 | 137,139 | 09/25/23 |
Mendelson Daniel Newman | Director Director | Sep 22 | Buy | 5.50 | 3,812 | 20,966 | 140,951 | 09/25/23 |